Agranulocytosis and bone marrow aplasia induced by second-line drugs for rheumatoid arthritis. Treatment with granulocyte colony-stimulating factor.
Sayag-Boukris
V
V
Ziza
J M
JM
Brice
P
P
Wechsler
B
B
D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced*; D000741:Anemia, Aplastic / Q000139:chemically induced*; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D005260:Female; D017612:Gold Compounds / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000009:adverse effects* / Q000627:therapeutic use
D018501:Antirheumatic Agents; D017612:Gold Compounds; D008727:Methotrexate